LANOVA MEDICINES LIMITED

Organization

SHANGHAI, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-claudin 18.2 antibodies and uses thereof
- Patent number 12,018,076
- Issue date Jun 25, 2024
- LaNova Medicines Limited Company
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CCR8 monoclonal antibodies and uses thereof
- Patent number 11,873,342
- Issue date Jan 16, 2024
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates targeting human Claudin 18.2
- Patent number 11,554,177
- Issue date Jan 17, 2023
- LaNova Medicines Limited Company
- RunSheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-claudin 18.2 antibodies and uses thereof
- Patent number 11,098,118
- Issue date Aug 24, 2021
- LaNova Medicines Limited Company
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-claudin 18.2 antibodies and uses thereof
- Patent number 11,059,887
- Issue date Jul 13, 2021
- LaNova Medicines Limited Company
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitor and application thereof
- Patent number 10,882,853
- Issue date Jan 5, 2021
- LaNova Medicines Limited
- Fang Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-4-1BB NANOBODIES
- Publication number 20240383993
- Publication date Nov 21, 2024
- LaNova Medicines Limited
- Runsheng LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING LIV-1 AND USES THEREOF
- Publication number 20240325555
- Publication date Oct 3, 2024
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6
- Publication number 20240317851
- Publication date Sep 26, 2024
- LaNova Medicines Limited
- Runsheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEACAM5-DEPENDENT 4-1BB-AGONISTIC BISPECIFIC ANTIBODIES
- Publication number 20240294656
- Publication date Sep 5, 2024
- LaNova Medicines Limited
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20240262841
- Publication date Aug 8, 2024
- LaNova Medicines Limited
- Runsheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20240141052
- Publication date May 2, 2024
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2
- Publication number 20230330253
- Publication date Oct 19, 2023
- LaNova Medicines Limited Company
- RunSheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220195057
- Publication date Jun 23, 2022
- LaNova Medicines Limited
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2
- Publication number 20220168437
- Publication date Jun 2, 2022
- LaNova Medicines Limited Company
- RunSheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SIRPalpha MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220169726
- Publication date Jun 2, 2022
- LaNova Medicines Limited Company
- RunSheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF
- Publication number 20210380681
- Publication date Dec 9, 2021
- LaNova Medicines Limited Company
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF
- Publication number 20210171628
- Publication date Jun 10, 2021
- LaNova Medicines Limited Company
- Runsheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF
- Publication number 20200385463
- Publication date Dec 10, 2020
- LaNova Medicines Limited Company
- Runsheng Li
- C07 - ORGANIC CHEMISTRY

LANOVA MEDICINES LIMITED

Organization

Patents Grantslast 30 patents

Anti-claudin 18.2 antibodies and uses thereof

Anti-CCR8 monoclonal antibodies and uses thereof

Antibody-drug conjugates targeting human Claudin 18.2

Anti-claudin 18.2 antibodies and uses thereof

Anti-claudin 18.2 antibodies and uses thereof

Tyrosine kinase inhibitor and application thereof

Patents Applicationslast 30 patents

ANTI-4-1BB NANOBODIES

ANTIBODIES TARGETING LIV-1 AND USES THEREOF

ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6

CEACAM5-DEPENDENT 4-1BB-AGONISTIC BISPECIFIC ANTIBODIES

COMPOUNDS, COMPOSITIONS AND METHODS

ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2

ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2

ANTI-SIRPalpha MONOCLONAL ANTIBODIES AND USES THEREOF

ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF

ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF

ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF

Trademarklast 30 trademarks